Bayer Aktie News

BERLIN & SAN DIEGO--(BUSINESS WIRE)--Bayer and CrossBay Medical Inc., today announced a development and option to license agreement that will allow the development and production of a single-handed inserter to be combined with Bayer's leading hormonal IUS portfolio. The partnership will result in the further development and expansion of CrossBay's existing innovative CrossGlide™ technology. The...

SAN FRANCISCO & BASEL, Switzerland--(BUSINESS WIRE)--Hurdle, a pioneer in diagnostic testing, and the Consumer Health division of Bayer have launched a strategic partnership to advance consumer innovations in the emerging area of healthy aging. The partnership is designed to enhance the companies' shared ambition to transform self-care through personalized solutions. This alliance integrates Hu...

Bayer has made incredible strides— from traditional medications and artificial intelligence to radiology and crop science.

The market continues to rip higher in November, with the S&P 500 up 9% since Halloween. However, not all stocks are participating in the rally.

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced today the publication of a novel health economic model in the Journal of Medical Economics, funded by Bayer, analyzing cost effectiveness and infrastructural capacity of supplemental imaging modalities for women with dense breasts at average or intermediate risk of breast cancer. The results of the model demonstrated all investigated supplemental...

Bayer held a call with investors on Monday after a raft of bad news led some of them to question whether the German group had been upfront about its prospects ahead of a $5.75 billion bond issuance, three sources familiar with the situation said on Wednesday.

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer continues to advance its comprehensive Radiology portfolio with progress in the development pipeline for an investigational contrast agent as well as new innovations in the area of Artificial Intelligence (AI). The company announced that new clinical data for gadoquatrane, Bayer's investigative macrocyclic gadolinium-based compound currently in Phase III d...

Bayer was ordered to pay $1.56 billion to four plaintiffs after a Missouri judge ruled that the company's Roundup weedkiller caused cancer. A Cole County, Mo.